The Kyrgyz Republic Approves Single Dose COVID-19 Vaccine

The Russian Direct Investment Fund announced on June 25, 2021, the approval of the single-dose Sputnik Light vaccine by the Ministry of Health of the Kyrgyz Republic.

Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of the two-dose Sputnik V vaccine.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said in a press statement, “Registration of Sputnik Light in Kyrgyzstan will help provide the country with another highly effective and safe vaccine against coronavirus. In addition, single-dose Sputnik Light vaccine will enable authorities to speed up the vaccination of the population and accelerate the creation of herd immunity.”

Kyrgyzstan is a country of about 6.5 million residents located in Central Asia, says Britannica. As of June 24, 2021, the government of Kyrgyzstan confirmed 1,958 deaths during the COVID-19 pandemic.